The Rational Use of Complement Inhibitors in Kidney Diseases

The development of complement inhibitors represented one of the major breakthroughs in clinical nephrology in the last decade. Complement inhibition has dramatically transformed the outcome of one of the most severe kidney diseases, the atypical hemolytic uremic syndrome (aHUS), a prototypic complem...

Descripción completa

Detalles Bibliográficos
Autores principales: Fakhouri, Fadi, Schwotzer, Nora, Golshayan, Déla, Frémeaux-Bacchi, Véronique
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171628/
https://www.ncbi.nlm.nih.gov/pubmed/35685323
http://dx.doi.org/10.1016/j.ekir.2022.02.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171628/
https://www.ncbi.nlm.nih.gov/pubmed/35685323
http://dx.doi.org/10.1016/j.ekir.2022.02.021

Ejemplares similares